866-997-4948(US-Canada Toll Free)

Immunohematology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Published By :

Transparency Market Research

Published Date : Mar 2018

Category :

Biotechnology

No. of Pages : 216 Pages

Immunohematology Market: Scope and Methodology

This report on the global immunohematology market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research represents a bulk of our research efforts along with the information collected from telephonic interviews and interactions via e-mails. Secondary research involves the study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates of each segment of the global immunohematology market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. The report also provides insights into the key trends in the immunohematology market such as shift toward automated systems, result comparability, and standardization to adhere to the international accreditations, significant number of product approvals, and strategic alliances. The key market indicators influencing the global immunohematology market taken into consideration include cost constraints and regulatory landscape. The report also contains market attractiveness analysis of the major segments, which provides a thorough analysis of the overall competition scenario in the global immunohematology market. The report also comprises Porter’s five forces analysis of the global immunohematology market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 and the compounded annual growth rate (CAGR %) for the period from 2017 to 2025 have been provided for all segments, considering 2016 as the base year. The year-on-year growth of the global immunohematology market for each segment has also been provided. Additionally, market-related factors such as technological advancements, changing environmental factors, growing initiatives to create disease awareness, increasing affordability for patients in various geographies, and historical year-on-year growth have been taken into consideration while estimating the market size.

Immunohematology Market: Segmentation

Based on product, the global immunohematology market has been segmented into analyzers (automatic and semi-automatic/non-automatic) and reagents. Based on application, the market has been divided into blood typing and antibody screening. In terms of end-user, the market has been segmented into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks. The hospitals segment is expected to remain dominant throughout the forecast period.

Geographically, the global immunohematology market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Every region has been further segmented into major countries in the respective region. These include the U.S. and Canada (North America), the U.K., Germany, France, Italy, and Spain (Europe), China, Australia, Japan, and India (Asia Pacific), Brazil and Mexico (Latin America), and GCC and South Africa (Middle East & Africa).

Immunohematology Market: Competition Landscape

The report also profiles major players in the immunohematology market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. A thorough market share analysis of major companies operating in the immunohematology market has been provided in the report. Key companies profiled in the report are Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers.

The global immunohematology market has been segmented as follows:

Global Immunohematology Market, by Product

  • Immunohematology Analyzers 
    • Automatic
    • Semi-automatic/Non-automatic
  • Immunohematology Reagents   

Global Immunohematology Market, by Application

  • Blood Typing
  • Antibody Screening

Global Immunohematology Market, by End-user

  • Hospitals
    • 500+ Beds
    • 200–499 Beds
    • Less Than 200 Beds
  • Academic & Research Institutes
  • Diagnostic & Reference Laboratories
  • Blood Banks

 Global Immunohematology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Content

Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Immunohematology Market Snapshot
3.2 Market Share Analysis, by Region, 2016
3.3 Market Opportunity Map

Section 4 Market Overview
4.1 Immunohematology Market Taxonomy
4.2 Key Market Advancements
4.3 Global Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
4.4 Global Immunohematology Market Outlook

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Immunohematology Market: Porter’s Five Forces Analysis
5.6 Key Success Factors of Top 3 Companies
5.7 Estimated blood donations by WHO region , 2013
5.8 Healthcare Sector Overview

Section 6 Immunohematology Market Analysis, by Product
6.1 Introduction
6.2 Global Immunohematology Market Value Share Analysis, by Product
6.3 Global Immunohematology Market Forecast, by Product
6.3.1 Analyzers
6.3.1.1 Automatic
6.3.1.2 Semi-automatic/Non-automatic
6.3.2 Reagents
6.4 Market Attractiveness Analysis, by Product
6.5 Key Trends

Section 7 Immunohematology Market Analysis, by Application
7.1 Introduction
7.2 Global Immunohematology Market Value Share Analysis, by Application
7.3 Global Immunohematology Market Forecast, by Application
7.3.1 Blood Typing
7.3.2 Antibody Screening
7.4 Market Attractiveness Analysis, by Application
7.5 Key Trends

Section 8 Immunohematology Market Analysis, by End-user
8.1 Introduction
8.2 Global Immunohematology Market Value Share Analysis, by End-user
8.3 Global Immunohematology Market Forecast, by End-user
8.3.1 Hospitals
8.3.1.1 500+ Beds
8.3.1.2 200–499 Beds
8.3.1.3 Less Than 200 Beds
8.3.2 Academic & Research Institutes
8.3.3 Diagnostic & Reference Laboratories
8.3.4 Blood Banks
8.4 Market Attractiveness Analysis, by End-user

Section 9 Immunohematology Market Analysis, by Region
9.1 Global Immunohematology Market Scenario
9.2 Global Immunohematology Market Value Share Analysis, by Region
9.3 Global Immunohematology Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10 North America Immunohematology Market Analysis
10.1 Regional Outlook
10.2 Market Overview
10.3 Market Analysis, by Product
10.3.1 Market Value Share Analysis, by Product
10.3.2 Market Size (US$ Mn) Forecast, by Product
10.3.2.1 Analyzers
 10.3.2.1.1 Automatic
 10.3.2.1.2 Semi-automatic/Non-automatic
10.3.2.2 Reagents
10.4 Market Analysis, by Application
10.4.1 Market Value Share Analysis, by Application
10.4.2 Market Size (US$ Mn) Forecast, by Application
10.4.2.1 Blood Typing
10.4.2.2 Antibody Screening
10.5 Market Analysis, by End-user
10.5.1 Market Value Share Analysis, by End-user
10.5.2 Market Size (US$ Mn) Forecast, by End-user
10.5.2.1 Hospitals
 10.5.2.1.1 500+ Beds
 10.5.2.1.2 200–499 Beds
 10.5.2.1.3 Less Than 200 Beds
10.5.2.2 Academic & Research Institutes
10.5.2.3 Diagnostic & Reference Laboratories
10.5.2.4 Blood Banks
10.6 Market Analysis, by Country
10.6.1 Market Value Share Analysis, by Country
10.6.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
10.6.2.1 U.S.
 10.6.2.1.1 U.S. Market Size (US$ Mn) Forecast, by Product
 10.6.2.1.2 U.S. Market Size (US$ Mn) Forecast, by Application
 10.6.2.1.3 U.S. Market Size (US$ Mn) Forecast, by End-user
10.6.2.2 Canada
10.7 Market Attractiveness Analysis
10.7.1 by Country
10.7.2 by Product
10.7.3 by Application
10.7.4 by End-user

Section 11 Europe Immunohematology Market Analysis
11.1 Regional Outlook
11.2 Market Overview
11.3 Market Analysis, by Product
11.3.1 Market Value Share Analysis, by Product
11.3.2 Market Size (US$ Mn) Forecast, by Product
11.3.2.1 Analyzers
 11.3.2.1.1 Automatic
 11.3.2.1.2 Semi-automatic/Non-automatic
11.3.2.2 Reagents
11.4 Market Analysis, by Application
11.4.1 Market Value Share Analysis, by Application
11.4.2 Market Size (US$ Mn) Forecast, by Application
11.4.2.1 Blood Typing
11.4.2.2 Antibody Screening
11.5 Market Analysis, by End-user
11.5.1 Market Value Share Analysis, by End-user
11.5.2 Market Size (US$ Mn) Forecast, by End-user
11.5.2.1 Hospitals
 11.5.2.1.1 500+ Beds
 11.5.2.1.2 200–499 Beds
 11.5.2.1.3 Less Than 200 Beds
11.5.2.2 Academic & Research Institutes
11.5.2.3 Diagnostic & Reference Laboratories
11.5.2.4 Blood Banks
11.6 Market Analysis, by Country/Sub-region
11.6.1 Market Value Share Analysis, by Country/Sub-region
11.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
11.6.2.1 U.K.
11.6.2.2 Germany
11.6.2.3 France
11.6.2.4 Spain
11.6.2.5 Italy
11.6.2.6 Rest of Europe
11.7 Market Attractiveness Analysis
11.7.1 by Country/Sub-region
11.7.2 by Product
11.7.3 by Application
11.7.4 by End-user

Section 12 Asia Pacific Immunohematology Market Analysis
12.1 Regional Outlook
12.2 Market Overview
12.3 Market Analysis, by Product
12.3.1 Market Value Share Analysis, by Product
12.3.2 Market Size (US$ Mn) Forecast, by Product
12.3.2.1 Analyzers
 12.3.2.1.1 Automatic
 12.3.2.1.2 Semi-automatic/Non-automatic
12.3.2.2 Reagents
12.4 Market Analysis, by Application
12.4.1 Market Value Share Analysis, by Application
12.4.2 Market Size (US$ Mn) Forecast, by Application
12.4.2.1 Blood Typing
12.4.2.2 Antibody Screening
12.5 Market Analysis, by End-user
12.5.1 Market Value Share Analysis, by End-user
12.5.2 Market Size (US$ Mn) Forecast, by End-user
12.5.2.1 Hospitals
 12.5.2.1.1 500+ Beds
 12.5.2.1.2 200–499 Beds
 12.5.2.1.3 Less Than 200 Beds
12.5.2.2 Academic & Research Institutes
12.5.2.3 Diagnostic & Reference Laboratories
12.5.2.4 Blood Banks
12.6 Market Analysis, by Country/Sub-region
12.6.1 Market Value Share Analysis, by Country/Sub-region
12.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
12.6.2.1 Australia & New Zealand
12.6.2.2 Japan
12.6.2.3 China
12.6.2.4 India
12.6.2.5 Rest of Asia Pacific
12.7 Market Attractiveness Analysis
12.7.1 by Country/Sub-region
12.7.2 by Product
12.7.3 by Application
12.7.4 by End-user

Section 13 Latin America Immunohematology Market Analysis
13.1 Regional Outlook
13.2 Market Overview
13.3 Market Analysis, by Product
13.3.1 Market Value Share Analysis, by Product
13.3.2 Market Size (US$ Mn) Forecast, by Product
13.3.2.1 Analyzers
 13.3.2.1.1 Automatic
 13.3.2.1.2 Semi-automatic/Non-automatic
13.3.2.2 Reagents
13.4 Market Analysis, by Application
13.4.1 Market Value Share Analysis, by Application
13.4.2 Market Size (US$ Mn) Forecast, by Application
13.4.2.1 Blood Typing
13.4.2.2 Antibody Screening
13.5 Market Analysis, by End-user
13.5.1 Market Value Share Analysis, by End-user
13.5.2 Market Size (US$ Mn) Forecast, by End-user
13.5.2.1 Hospitals
 13.5.2.1.1 500+ Beds
 13.5.2.1.2 200–499 Beds
 13.5.2.1.3 Less Than 200 Beds
13.5.2.2 Academic & Research Institutes
13.5.2.3 Diagnostic & Reference Laboratories
13.5.2.4 Blood Banks
13.6 Market Analysis, by Country/Sub-region
13.6.1 Market Value Share Analysis, by Country/Sub-region
13.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
13.6.2.1 Brazil
13.6.2.2 Mexico
13.6.2.3 Rest of Latin America
13.7 Market Attractiveness Analysis
13.7.1 by Country/Sub-region
13.7.2 by Product
13.7.3 by Application
13.7.4 by End-user

Section 14 Middle East & Africa Immunohematology Market Analysis
14.1 Regional Outlook
14.2 Market Overview
14.3 Market Analysis, by Product
14.3.1 Market Value Share Analysis, by Product
14.3.2 Market Size (US$ Mn) Forecast, by Product
14.3.2.1 Analyzers
 14.3.2.1.1 Automatic
 14.3.2.1.2 Semi-automatic/Non-automatic
14.3.2.2 Reagents
14.4 Market Analysis, by Application
14.4.1 Market Value Share Analysis, by Application
14.4.2 Market Size (US$ Mn) Forecast, by Application
14.4.2.1 Blood Typing
14.4.2.2 Antibody Screening
14.5 Market Analysis, by End-user
14.5.1 Market Value Share Analysis, by End-user
14.5.2 Market Size (US$ Mn) Forecast, by End-user
14.5.2.1 Hospitals
 14.5.2.1.1 500+ Beds
 14.5.2.1.2 200–499 Beds
 14.5.2.1.3 Less Than 200 Beds
14.5.2.2 Academic & Research Institutes
14.5.2.3 Diagnostic & Reference Laboratories
14.5.2.4 Blood Banks
14.6 Market Analysis, by Country/Sub-region
14.6.1 Market Value Share Analysis, by Country/Sub-region
14.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
14.6.2.1 South Africa
14.6.2.2 GCC
14.6.2.3 South Africa
14.6.2.4 Israel
14.6.2.5 Rest of Middle East & Africa
14.7 Market Attractiveness Analysis
14.7.1 by Country/Sub-region
14.7.2 by Product
14.7.3 by Application
14.7.4 by End-user

Section 15 Company Profiles
15.1 Immunohematology Market Share Analysis, by Company (2016)
15.2 Company Profiles
15.2.1 Bio-Rad Laboratories, Inc.
15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2 Financial Overview
15.2.1.3 Product Portfolio
15.2.1.4 SWOT Analysis
15.2.1.5 Strategic Overview
15.2.2 Grifols, S.A.
15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2 Financial Overview
15.2.2.3 Product Portfolio
15.2.2.4 SWOT Analysis
15.2.2.5 Strategic Overview
15.2.3 Ortho Clinical Diagnostics
15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2 Financial Overview
15.2.3.3 Product Portfolio
15.2.3.4 SWOT Analysis
15.2.3.5 Strategic Overview
15.2.4 IMMUCOR, INC.
15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2 Financial Overview
15.2.4.3 Product Portfolio
15.2.4.4 SWOT Analysis
15.2.4.5 Strategic Overview
15.2.5 Abbott Laboratories
15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2 Financial Overview
15.2.5.3 Product Portfolio
15.2.5.4 SWOT Analysis
15.2.5.5 Strategic Overview
15.2.6 Beckman Coulter, Inc.
15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2 Financial Overview
15.2.6.3 Product Portfolio
15.2.6.4 SWOT Analysis
15.2.6.5 Strategic Overview
15.2.7 Thermo Fisher Scientific, Inc.
15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2 Financial Overview
15.2.7.3 Product Portfolio
15.2.7.4 SWOT Analysis
15.2.7.5 Strategic Overview
15.2.8 Becton, Dickinson and Company
15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2 Financial Overview
15.2.8.3 Product Portfolio
15.2.8.4 SWOT Analysis
15.2.8.5 Strategic Overview
15.2.9 Merck KGaA
15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2 Financial Overview
15.2.9.3 Product Portfolio
15.2.9.4 SWOT Analysis
15.2.9.5 Strategic Overview
15.2.10 Siemens Healthineers14.2.5 Merck & Co., Inc.
15.2.10.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2 Financial Overview
15.2.10.3 Product Portfolio
15.2.10.4 SWOT Analysis
15.2.10.5 Strategic Overview

List of Table

Table 01: Global Immunohematology Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 03: Global Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 04: Global Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 05: Global Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 06: Global Immunohematology Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 07: North America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 08: North America Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 09: North America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 10: North America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 11: North America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 12: North America Immunohematology Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 13: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 14: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 15: U.S. Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 17: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals (by Analyzers), 2015–2025
Table 18: Europe Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 19: Europe Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 20: Europe Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 21: Europe Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 22: Europe Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 23: Europe Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 24: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 25: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 26: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 27: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 28: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 29: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 30: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 31: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Analyzer, 2015–2025
Table 32: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33: Latin America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 34: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 36: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 37: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 38: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 39: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 40: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 41: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 42: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

List of Chart

Figure 01: Global Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 02: Market Value Share, by Product (2016)
Figure 03: Market Value Share, by Application (2016)
Figure 04: Market Value Share, by Region (2016)
Figure 05: Global Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 06: Global Immunohematology Market Value Share Analysis, by Analyzers, 2016 and 2025
Figure 07: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2015–2025
Figure 08: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2015–2025
Figure 09: Global Immunohematology Market Attractiveness Analysis, by Product
Figure 10: Global Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 11: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Typing, 2015–2025
Figure 12: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antibody Screening, 2015–2025
Figure 13: Global Immunohematology Market Attractiveness, by Application
Figure 14: Global Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 15: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2015–2025
Figure 16: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Institutes, 2015–2025
Figure 17: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic & Reference Laboratories, 2015–2025
Figure 18: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Banks, 2015–2025
Figure 19: Global Immunohematology Market Attractiveness, by End-user
Figure 20: Global Immunohematology Market Value Share, by Region, 2016 and 2025
Figure 21: Global Immunohematology Market Attractiveness, by Region
Figure 22: North America Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
Figure 23: North America Market Attractiveness Analysis, by Country
Figure 24: North America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 25: North America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
Figure 26: North America Immunohematology Market Value Share Analysis, by End-user, 2016 and 2024
Figure 27: North America Immunohematology Market Value Share Analysis, by Country, 2016 and 2025
Figure 28: North America Immunohematology Market Attractiveness Analysis, by Product
Figure 29: North America Immunohematology Market Attractiveness Analysis, by Application
Figure 30: North America Immunohematology Market Attractiveness Analysis, by End-user
Figure 31: Europe Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
Figure 32: Europe Immunohematology Market Attractiveness, by Country/Sub-region
Figure 33: Europe Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 34: Europe Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 35: Europe Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 36: Europe Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 37: Europe Immunohematology Market Attractiveness, by Product
Figure 38: Europe Immunohematology Market Attractiveness, by Application
Figure 39: Europe Immunohematology Market Attractiveness,  by End-user
Figure 40: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 41: Asia Pacific Immunohematology Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 42: Asia Pacific Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 43: Asia Pacific Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 44: Asia Pacific Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 45: Asia Pacific Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 46: Asia Pacific Immunohematology Market Attractiveness, by Product
Figure 47: Asia Pacific Immunohematology Market Attractiveness, by Application
Figure 48: Asia Pacific Immunohematology Market Attractiveness, by End-user
Figure 49: Latin America Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 50: Latin America Immunohematology Market Attractiveness Analysis, by Country/Sub-region, 2017-25
Figure 51: Latin America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 52: Latin America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
Figure 53: Latin America Immunohematology Market Value Share Analysis by End-user, 2016 and 2024
Figure 54: Latin America Immunohematology Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 55: Latin America Immunohematology Market Attractiveness Analysis, by Product
Figure 56: Latin America Immunohematology Market Attractiveness Analysis, by Application
Figure 57: Latin America Immunohematology Market Attractiveness Analysis, by End-user
Figure 58: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Middle East & Africa Immunohematology Market Attractiveness, by Country/Sub-region
Figure 60: Middle East & Africa Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 61: Middle East & Africa Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 62: Middle East & Africa Immunohematology Market Value Share, by End-user, 2016 and 2024
Figure 63: Middle East & Africa Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 64: Middle East & Africa Immunohematology Market Attractiveness, by Product
Figure 65: Middle East & Africa Immunohematology Market Attractiveness, by Application
Figure 66: Middle East & Africa Immunohematology Market Attractiveness, by End-user
Figure 67: Market Share of Prominent Key Players: Immunohematology Market, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *